Organization · Venture Capital
Aliath Bioventures
Aliath Bioventures is a life sciences venture investor focused on therapeutics, diagnostics, and health technologies. It operates under the AltamarCAM umbrella and emphasizes impact-oriented investments in Europe.
Overview
What Aliath Bioventures does
What Aliath Bioventures is
Aliath Bioventures is a life sciences venture investor focused on therapeutics, diagnostics, and health technologies. It operates under the AltamarCAM umbrella and emphasizes impact-oriented investments in Europe.
How it participates in the startup ecosystem
The current public profile supports funder capabilities. Each capability below is shown separately so organization identity and role-specific information do not get conflated.
Operational profile
Organization status and context
Organization status describes the entity itself. Funding and program availability appear within the relevant capability profile.
- Operational status
- Active
- Organization type
- Venture Capital
- Structured capabilities
- Funder
- Last reviewed
- April 26, 2026
Official channels
Find Aliath Bioventures elsewhere
Open the official website or a supported primary organization account.
Capability profile
Aliath Bioventures as a funder
Investment thesis
Aliath Bioventures seeks disruptive technologies that address unmet medical needs, improve healthcare access, and enhance system efficiency, evaluating opportunities with scientific, financial, sustainability, and impact considerations.
Focus narrative
Aliath Bioventures invests across various asset classes, including venture capital and private equity, with a strong emphasis on life sciences. The organization employs a collaborative investment strategy that includes primaries, secondaries, co-investments, and direct investments, all while maintaining a rigorous ESG focus.
Value beyond capital
Aliath Bioventures adds value by working closely with portfolio companies, providing expertise, capital, and a robust network to help achieve value-creating milestones. The firm typically takes board positions to ensure active involvement in governance and strategic direction.
Focus and fit
- Stages
- Seed · Series A · Series B · Growth Equity
- Sectors
- Biotech · Healthcare · Digital Health · Medical Devices
- Regions
- Europe · Global
Availability
- Currently deploying
- Yes
Portfolio and track record
Portfolio context
INBRAIN Neuroelectronics: Developing a graphene brain-computer interface. Inbiomotion: Innovating early-stage breast cancer treatment guidance with the MAF Test. deepull: Advancing rapid pathogen detection systems with a recent EUR 50 million Series C funding. Peptomyc: Focused on innovative cancer therapies. Accure Therapeutics: Supporting clinical trials for Parkinson's disease treatments. binx health: Engaged in health technology solutions.
Common questions
What to know about Aliath Bioventures
Upseed classifies Aliath Bioventures under the Venture Capital organization type. Its current public profile includes funder capabilities.
Source and update disclosure
Know what this page is based on
Source basis
Public organization and program material, official websites, and structured Upseed records.
Last reviewed
April 26, 2026
Known limits
Capability profiles appear only when a structured public profile also contains decision-useful role evidence. Terms and availability can change.
Upseed is an independent guide. It is not affiliated with or endorsed by the organization described on this page.